Status:
RECRUITING
Essen Amyloidosis Registry
Lead Sponsor:
University Hospital, Essen
Conditions:
Amyloidosis; Systemic
Amyloidosis Cardiac
Eligibility:
All Genders
18+ years
Brief Summary
The Essen Amyloidosis Registry (EAR) is a prospective, observational registry designed to collect comprehensive clinical data on patients diagnosed with systemic amyloidosis. The registry aims to impr...
Detailed Description
The Essen Amyloidosis Registry (EAR) is a single-center, prospective, observational registry designed to systematically collect clinical, laboratory, imaging, and outcome data from patients with suspe...
Eligibility Criteria
Inclusion
- Suspected or confirmed amyloidosis (any)
- Written informed consent to participate in the study
- Age 18 years and above
Exclusion
- Age \< 18 years
- Lack of written informed consent
Key Trial Info
Start Date :
May 8 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2029
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06887283
Start Date
May 8 2024
End Date
July 1 2029
Last Update
August 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Essen
Essen, North Rhine-Westphalia, Germany, 45147